Related Experiment Videos
Longitudinal P300 latency changes in Alzheimer's disease
S S Ball1, J T Marsh, G Schubarth
1Department of Pathology, University of California, Los Angeles.
Summary
Alzheimer's disease patients show prolonged P300 latency, an auditory brain potential marker. This latency increases faster in AD patients over three years, suggesting accelerated brain aging.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Science
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Auditory event-related potentials, specifically the P300 (P3) wave, are sensitive to cognitive function.
- Changes in P3 latency may indicate underlying neurobiological alterations in aging and dementia.
Purpose of the Study:
- To longitudinally assess changes in P300 latency in patients with possible and probable Alzheimer's disease (pAD) compared to normal controls.
- To investigate if the rate of P3 latency change differs between pAD patients and controls over time.
- To explore the potential of auditory P300 latency as a biomarker for neurobiological changes in AD.
Main Methods:
- A longitudinal study design was employed.
- Participants included 18 individuals diagnosed with pAD and 15 healthy controls.
- Auditory event-related potentials, focusing on P300 latency, were recorded and analyzed over a 3-year period.
Main Results:
- Initially, pAD patients exhibited significantly prolonged P300 latency (over 1.5 standard deviations, 40 msec longer) compared to controls.
- The rate of increase in P300 latency over three years was significantly greater in the pAD group than in the control group.
- These findings suggest a differential progression of neurophysiological changes in AD.
Conclusions:
- P300 latency is significantly altered in individuals with Alzheimer's disease.
- The accelerated increase in P300 latency in pAD patients may reflect accelerated senescence.
- Auditory P300 latency holds potential as a neurobiological marker for aging and dementia processes.